Screener
Tandem Diabetes Care TNDM Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 56%+3.5pp | 54.9%+2.7pp | 53.8%+1.7pp | 53.2%+3.4pp | 52.5%+3.5pp | |
| Operating margin | -4.4%+15.5pp | -8.2%+10.0pp | -18.5%-7.9pp | -19.5%-3.8pp | -19.9%-2.4pp | |
| Net margin | -6.1%+14.4pp | -9.2%+9.5pp | -20.2%-10.0pp | -20.2%-5.4pp | -20.5%-3.4pp | |
| Returns | ||||||
| Return on equity | -48%+63.9pp | -65.7%+26.6pp | -97.9%-64.6pp | -109.7%-63.8pp | -111.9%-63.4pp | |
| Return on invested capital | -6.9%+25.7pp | -13.1%+26.2pp | -30.8%-16.4pp | -32.8%-7.9pp | -32.6%-5.8pp | |
| Efficiency | ||||||
| Asset turnover | 1×-0.1× | 1×-0.1× | 1.1×+0.1× | 1.1×+0.2× | 1.1×+0.3× | |
| Liquidity | ||||||
| Current ratio | 3.2×+0.7× | 3.6×+1.3× | 2.5×-0.4× | 2.4×-0.5× | 2.4×-0.6× | |
| Leverage | ||||||
| Debt-to-equity | 5.7×+2.3× | 5.5×+2.4× | 2.9×+0.9× | 3.4×+1.2× | 3.4×+1.2× | |
| Per Share | ||||||
| Book value per share | $1.89-5.0% | $1.94-17.2% | $2.28-42.6% | $1.97-45.8% | $1.99-44.8% | |
| Valuation | ||||||
| Market capitalization | $1.29B+34.3% | $1.31B+2.8% | $1.49B-37.0% | $820.29M-70.5% | $1.34B-48.3% | |
| Price / sales | 1.2×+0.3× | 1.3×0.0× | 1.5×-1.0× | 0.8×-2.4× | 1.3×-1.9× | |
| Price / book | 9.9×+2.7× | 9.9×+1.7× | 9.6×+0.6× | 6.2×-5.5× | 10.1×-1.0× |
FAQ
- What are Tandem Diabetes Care's profit margins?
- Tandem Diabetes Care (TNDM) runs a 56.0% gross margin and a -4.4% operating margin, with a -6.1% net margin.
- Where do Tandem Diabetes Care's ratios come from?
- Every ratio is computed from Tandem Diabetes Care's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
